6-Chloro-3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazine

Catalog No. :
ACDLNY785
CAS No. :
1094260-38-4
Molecular Formula :
C10H6ClN5
Molecular Weight :
231.65

IUPAC Name:6-chloro-3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazine

6-Chloro-3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$228.00Login to see priceInquiryInquiry
100mg98%$332.00Login to see priceInquiryInquiry
250mg98%$469.00Login to see priceInquiryInquiry
1g98%$928.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazine
IUPAC Name6-chloro-3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazine
Molecular FormulaC10H6ClN5
Molecular Weight231.65
SMILESClC1=NN2C(C=C1)=NN=C2C3=CC=CN=C3
InChI KeyAPXVJDJWZWKXIT-UHFFFAOYSA-N
Synonym6-chloro-3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazine;1,2,4-Triazolo[4,3-b]pyridazine, 6-chloro-3-(3-pyridinyl)-;3-{6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}pyridine
CAS No.1094260-38-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDLNY785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDLNY785 route product structure diagram
    ACDLNY7851094260-38-4
Inquiry

2. ACDLNY785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDLNY785 route product structure diagram
    ACDLNY7851094260-38-4
Inquiry

Comments (0)